TGN-073 is a aquaporin 4 (AQP4) modulator, as well as an orally available, blood-brain barrier-permeable agent. TGN-073 increases the uptake and distribution of brain MRI tracers in the brain parenchyma and reduces the levels of insoluble amyloid-beta 40 and beta 42. TGN-073 can be used in research related to Alzheimers disease, dementia, traumatic brain injury and pain[1][2][3].
Molecular Weight:
340.40
Purity:
99.53
CAS Number:
[877459-36-4]
Formula:
C18H16N2O3S
Target:
Aquaporin
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted